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CASE REPORTGrade 4 radiation dermatitis presenting with
full-thickness ulcerations of the groin after radiation
therapy for anal squamous cell carcinoma (SCC): An
example of the ‘‘bolus effect’’ of radiation therapy
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odern radiotherapy techniques for the
treatment of squamous cell carcinoma
(SCC) of the anus have led to a significant
reduction in the incidence and severity of skin
toxicity.1 However, grade 4 radiation dermatitis
remains a difficult complication of radiation therapy
for malignancies located in skin folds, a phenome-
non known as the ‘‘bolus effect.’’ We describe a case
of grade 4 radiation dermatitis in an HIV-positive
patient after intensity-modulated radiation therapy
(IMRT) for SCC of the anus, along with the manage-
ment of these lesions.CASE REPORT
A 56-year-old black manwith HIVon highly active
antiretroviral therapy with stage II SCC of the anus
treated with local excision, chemotherapy with 5-
fluoruracil and mitomycin, and IMRT (5 times/wk for
5 weeks, total: 50 Gy in 25 fractions) presented with
painful ulcers in his groin and perianal region. The
patient initiated IMRT 2 months before presentation.
Two weeks into IMRT he developed erythematous
patches of the perianal region consistent with moist
desquamation of grade 2 radiation dermatitis. These
areas were treated with saline soaks and antibiotic
soaps, and did not erode during the treatment
period.
One week after his last dose of radiation, the
patient developed increasing pain both perianally
and in the inguinal folds. Physical examination
revealed malodorous, geometric, sharply demar-
cated ulcers with central fibrinous exudatethe Department of Dermatology, Columbia University.
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2506@columbia.edu.symmetrically along the bilateral inguinal folds
(Fig 1, A). He had a similar 1.5-cm ulcer on the glans
penis, and a 20-cm ulcer extending confluently from
the anus along the bilateral buttocks, perineum, and
scrotum (Fig 1, B). There was no surrounding
cellulitis, edema, or purulent drainage. A punch
biopsy specimen of the inguinal ulcer showed
fibrosis and increased vascularity without evidence
of SCC, herpes simplex virus, or other infection. The
patient underwent debridement in the operating
suite, and wound care was performed with wet-to-
dry dressings with a plan for eventual split-thickness
skin grafting. However, the patient experienced
unrelated neurologic decline before skin grafting,
and was deemed ineligible for the procedure.DISCUSSION
Radiation dermatitis is a well-known complication
of radiation therapy, and is subtyped into 4 grades
based on clinical presentation. Acute radiation dam-
age to the skin is complex and involves inflammation,
endothelial cell changes, impairment of functional
stem cells, and epidermal apoptosis.2 Initially, radia-
tion exposure leads to development of transient, self-
limited erythematous patches and dry desquamation,
classified as grade 1 radiation dermatitis.2,3 After 4 to
5weeks of treatment, particularly in patients receiving
radiation doses of 40 Gy or greater, most patients
progress to grade 2 radiation dermatitis, which
clinicallymanifests with painful, erythematous, edem-
atous patches with moist desquamation.2,3 Histologic
examination at this stage reveals blister formation,JAAD Case Reports 2015;1:389-91.
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Fig 1. A, Grade 4 radiation dermatitis of the groin bilaterally. Ulcerations 10- to 20-mmwide by
6- to 9-mm deep. B, Grade 4 radiation dermatitis of gluteal region. A 20- 3 15-cm round ulcer
extending to the perineum and scrotum.
Fig 2. Transverse view of dose distribution from posterior-anterior axis.
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Progression to grade 4 radiation dermatitis, defined as
skin necrosis or ulceration of full-thickness dermis, is
rare and usually occurs 2 to 3months after completion
of therapy, often in associationwith infection or injury
to the area.2,4
Although skin necrosis has been seen in up to 10%
of patients undergoing radiation therapy for anal
cancer,5 the use of more advanced radiation delivery
techniques such as IMRT has significantly reduced
the incidence of both skin toxicity grades 3 or greater
and skin toxicity overall, with multiple studies
reporting no instances of grade 4 radiation dermatitis
using this technique.1,6,7 With IMRT, planning soft-
ware and computed tomography images are used to
vary not only radiation intensity, but also beam
shape, allowing precise radiation delivery that con-
forms to the tumor and spares normal tissue.6 Dosing
can be readjusted on each subsequent treatment for
maximum efficacy.
With a total treatment dose of 50 Gy, the patient’s
initial grade 2 dermatitis at the end of treatment wasexpected. The patient’s IMRT dose distribution
(Fig 2) demonstrates that the highest dose was
delivered to the primary tumor site, with an
additional focus along the inguinal lymph node
chains. However, the patient’s rapid progression to
grade 4 dermatitis was unexpected, occurring within
a month of termination of therapy. This is in the
absence of infection on culture and histologic
examination.
The severe ulceration of the inguinal folds and
gluteal cleft is a manifestation of the so-called bolus
effect of radiation therapy. In radiation therapy,
‘‘bolus’’ refers to a tissue equivalent material placed
on the skin to concentrate the dose of radiation
delivered by scattering entering electrons.8 In areas
of the body where skin is apposed, such as the groin
folds and gluteal cleft, the extra tissue layer acts as an
autologous bolus, delivering a higher dose of
radiation to the skin at that site, which can lead to
more severe skin toxicity.2 In addition, this patient’s
positive HIV status and race may also contribute to
his risk for developing severe skin toxicity. Despite
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HIV-positive and -negative individuals, a higher
incidence of grade 3 and 4 skin radiation dermatitis
has been reported in HIV-positive patients, poten-
tially attributable to a glutathione deficiency that
decreases cellular defense, and the radiosensitiza-
tion effects of highly active antiretroviral therapy.9,10
Differences in incidence and severity of radiation
dermatitis by race have also been reported, with
black patients more likely to experience at least
grade 2 radiation dermatitis after radiation.11 This
may be because of an increased incidence of a
specific genetic polymorphism in this population
involving the ATM gene, which encodes proteins for
cell cycle checkpoint control andDNA repair and has
been implicated as a predictor of late adverse radi-
ation effects, although further study is necessary.11,12
Treatment of radiation dermatitis is dependent
upon grade. Treatment for grade 1 is not indicated, as
the toxicity is self-limited. Grades 2 and 3 radiation
dermatitis are typically treated with basic wound
care, with or without topical barrier creams or
petrolatum. Grade 4 radiation dermatitis requires
specialized, often interdisciplinary wound care with
specific recommendations made on an individual
basis.13 Although radiation dermatitis is most often
managed by radiation oncologists in concert with
wound-care specialists, dermatologists should also
be aware of the natural history and treatment options
for complications arising from radiation therapy.REFERENCES
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